APOB

Gene Information
 
Gene Symbol
APOB
 
Aliases
FCHL2, FLDB, LDLCQ4, apoB-100, apoB-48
 
Entrez Gene ID
338
 
Gene Name
Apolipoprotein B
 
Chromosomal Location
2p24.1
 
HGNC ID
 
Summary
This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins (LDL), and is the ligand for the LDL receptor. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq, Dec 2019]
 
RefSeq DNA
 
RefSeq mRNA
  e!Ensembl
Gene
Transcript  
Protein

Gene Ontology (GO)

GO ID Ontology Function Evidence Reference
GO:0008203 Biological process Cholesterol metabolic process IMP 2563166
GO:0009615 Biological process Response to virus IEP 16548883
GO:0010744 Biological process Positive regulation of macrophage derived foam cell differentiation IDA 17244792, 18322245, 19114110
GO:0010884 Biological process Positive regulation of lipid storage IDA 18322245
GO:0010886 Biological process Positive regulation of cholesterol storage IDA 19114110
Protein Information
 
Protein Name
Apolipoprotein B-100, apolipoprotein B (including Ag(x) antigen), apolipoprotein B48
 
Function
Apolipoprotein B is a major protein constituent of chylomicrons (apo B-48), LDL (apo B-100) and VLDL (apo B-100). Apo B-100 functions as a recognition signal for the cellular binding and internalization of LDL particles by the apoB/E receptor
 
Refseq Proteins
 
UniProt
Pathways
 
KEGG
 
Reactome
 

Fat digestion and absorption
Vitamin digestion and absorption
Cholesterol metabolism

 

Cell surface interactions at the vascular wall
Scavenging by Class B Receptors
Scavenging by Class A Receptors
Scavenging by Class F Receptors
Scavenging by Class H Receptors
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
Platelet sensitization by LDL
Regulation of TLR by endogenous ligand
Cargo recognition for clathrin-mediated endocytosis
Clathrin-mediated endocytosis
VLDL assembly
Post-translational protein phosphorylation
Chylomicron assembly
Chylomicron remodeling
Chylomicron clearance
LDL clearance
LDL remodeling
VLDL clearance
Retinoid metabolism and transport

Interactions
 
STRING MINT IntAct
ENSP00000355896 P61812
    View interactions
     

Associated Diseases

Disease groupDisease NameReferences
Cardiovascular Diseases
Coronary heart disease
Digestive System Diseases
Fatty Liver
Endocrine System Diseases
PCOS
Immune System Diseases
Behcet Syndrome
Nutritional and Metabolic Diseases
Hypobetalipoproteinemias
References
 
 
PubMed ID Associated gene/s Associated condition Genetic Mutation Diagnostic Criteria Association with PCOS Ethnicity Conclusion
ApoA-I 
Dyslipidemia 
 
Rotterdam criteria 
Related 
Chinese-406 patients with PCOS and 342 control women between 17 and 40 years of age 
PCOS patients with dyslipidemia had significantly higher TG/HDL-C ratios, and lower HDL-C and apoA-I levels when compared with the controls or patients without dyslipidemia, and had significantly higher BMIs, fasting insulin concentrations, 2-h insulin and glucose levels, homeostatic model assessment IR, TG levels, LDL-C levels, atherogenic indexes, apoB concentrations and apoB/apoA-I ratios when compared with all of the control women, with or without dyslipidemia and patients without dyslipidemia. 
ApoA-I 
Metabolic syndrome 
 
 
Related 
Chinese-160 adolescent women 
The ApoB/ApoA1 ratio was a good predictive marker of MS and pre-MS in Chinese adolescent women with PCOS 
ApoA-I 
Dyslipidemia 
 
 
Related 
 
A significant finding was the decrease in ApoA1/ApoB ratio among the women with PCOS compared to both controls and obese women. 
MCP-1,ApoA-I 
 
 
 
Related 
 
PCOS obese and non-obese patients had higher serum MCP-1 levels than controls. MCP-1 was correlated with BMI, LH ,TG, ApoB and the ratio of ApoA/ ApoB. 
 
Hyperprolactinemia 
 
 
Related 
 
Patients with hyperPRL + PCOS develop the endocrine disturbances at a younger age, a greater incidence rate of acne, level of prolactin and androstenedione, they have reduced ApoB and increased HOMA-IR. 

| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412